Literature DB >> 22474372

Structures of KIX domain of CBP in complex with two FOXO3a transactivation domains reveal promiscuity and plasticity in coactivator recruitment.

Feng Wang1, Christopher B Marshall, Kazuo Yamamoto, Guang-Yao Li, Geneviève M C Gasmi-Seabrook, Hitoshi Okada, Tak W Mak, Mitsuhiko Ikura.   

Abstract

Forkhead box class O 3a (FOXO3a) is a transcription factor and tumor suppressor linked to longevity that determines cell fate through activating transcription of cell differentiation, survival, and apoptotic genes. Recruitment of the coactivator CBP/p300 is a crucial step in transcription, and we revealed that in addition to conserved region 3 (CR3) of FOXO3a, the C-terminal segment of CR2 (CR2C) binds CBP/p300 and contributes to transcriptional activity. CR2C and CR3 of FOXO3a interact with the KIX domain of CBP/p300 at both "MLL" and "c-Myb" binding sites simultaneously. A FOXO3a CR2C-CR3 peptide in complex with KIX exists in equilibrium between two equally populated conformational states, one of which has CR2C bound to the MLL site and CR3 bound to the c-Myb site, whereas in the other, CR2C and CR3 bind the c-Myb and MLL sites, respectively. This promiscuous interaction between FOXO3a and CBP/p300 is further supported by additional binding sites on CBP/p300, namely, the TAZ1 and TAZ2 domains. In functional studies, our structure-guided mutagenesis showed that both CR2C and CR3 are involved in the activation of certain endogenous FOXO3a target genes. Further, phosphorylation of S626, a known AMP-dependent protein kinase target in CR3, increased affinity for CBP/p300 and the phosphomimetic mutation enhanced transactivation of luciferase. These findings underscore the significance of promiscuous multivalent interactions and posttranslational modification in the recruitment of transcriptional coactivators, which may allow transcription factors to adapt to various gene-specific genomic and chromatin structures and respond to cell signals.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22474372      PMCID: PMC3341034          DOI: 10.1073/pnas.1119073109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Speeding molecular recognition by using the folding funnel: the fly-casting mechanism.

Authors:  B A Shoemaker; J J Portman; P G Wolynes
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

2.  MLL-AFX requires the transcriptional effector domains of AFX to transform myeloid progenitors and transdominantly interfere with forkhead protein function.

Authors:  Chi Wai So; Michael L Cleary
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

Review 3.  Biological control through regulated transcriptional coactivators.

Authors:  Bruce M Spiegelman; Reinhart Heinrich
Journal:  Cell       Date:  2004-10-15       Impact factor: 41.582

4.  Solution structure of the KIX domain of CBP bound to the transactivation domain of CREB: a model for activator:coactivator interactions.

Authors:  I Radhakrishnan; G C Pérez-Alvarado; D Parker; H J Dyson; M R Montminy; P E Wright
Journal:  Cell       Date:  1997-12-12       Impact factor: 41.582

5.  Structural and functional characterization of an atypical activation domain in erythroid Kruppel-like factor (EKLF).

Authors:  Caroline Mas; Mathieu Lussier-Price; Shefali Soni; Thomas Morse; Geneviève Arseneault; Paola Di Lello; Julien Lafrance-Vanasse; James J Bieker; James G Omichinski
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-13       Impact factor: 11.205

6.  Acetylation of Foxo1 alters its DNA-binding ability and sensitivity to phosphorylation.

Authors:  Hitomi Matsuzaki; Hiroaki Daitoku; Mitsutoki Hatta; Hisanori Aoyama; Kenji Yoshimochi; Akiyoshi Fukamizu
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-02       Impact factor: 11.205

7.  Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase.

Authors:  Anne Brunet; Lora B Sweeney; J Fitzhugh Sturgill; Katrin F Chua; Paul L Greer; Yingxi Lin; Hien Tran; Sarah E Ross; Raul Mostoslavsky; Haim Y Cohen; Linda S Hu; Hwei-Ling Cheng; Mark P Jedrychowski; Steven P Gygi; David A Sinclair; Frederick W Alt; Michael E Greenberg
Journal:  Science       Date:  2004-02-19       Impact factor: 47.728

8.  Common mechanism for oncogenic activation of MLL by forkhead family proteins.

Authors:  Chi Wai So; Michael L Cleary
Journal:  Blood       Date:  2002-08-22       Impact factor: 22.113

9.  The SIR2 gene family, conserved from bacteria to humans, functions in silencing, cell cycle progression, and chromosome stability.

Authors:  C B Brachmann; J M Sherman; S E Devine; E E Cameron; L Pillus; J D Boeke
Journal:  Genes Dev       Date:  1995-12-01       Impact factor: 11.361

10.  FoxO3a transcriptional regulation of Bim controls apoptosis in paclitaxel-treated breast cancer cell lines.

Authors:  Andrew Sunters; Silvia Fernández de Mattos; Marie Stahl; Jan J Brosens; Georgia Zoumpoulidou; Catherine A Saunders; Paul J Coffer; René H Medema; R Charles Coombes; Eric W-F Lam
Journal:  J Biol Chem       Date:  2003-10-03       Impact factor: 5.157

View more
  39 in total

1.  Molecular Basis for the Mechanism of Constitutive CBP/p300 Coactivator Recruitment by CRTC1-MAML2 and Its Implications in cAMP Signaling.

Authors:  Michael David Clark; Ganesan Senthil Kumar; Ryan Marcum; Qianyi Luo; Yongbo Zhang; Ishwar Radhakrishnan
Journal:  Biochemistry       Date:  2015-08-21       Impact factor: 3.162

2.  Sequence and expression analyses of KIX domain proteins suggest their importance in seed development and determination of seed size in rice, and genome stability in Arabidopsis.

Authors:  Jitendra Kumar Thakur; Pinky Agarwal; Swarup Parida; Deepak Bajaj; Richa Pasrija
Journal:  Mol Genet Genomics       Date:  2013-06-12       Impact factor: 3.291

Review 3.  Forkhead followed by disordered tail: The intrinsically disordered regions of FOXO3a.

Authors:  Feng Wang; Christopher B Marshall; Mitsuhiko Ikura
Journal:  Intrinsically Disord Proteins       Date:  2015-06-03

Review 4.  FOXO in Neural Cells and Diseases of the Nervous System.

Authors:  Evan E Santo; Jihye Paik
Journal:  Curr Top Dev Biol       Date:  2018-02-03       Impact factor: 4.897

Review 5.  FOXOs: signalling integrators for homeostasis maintenance.

Authors:  Astrid Eijkelenboom; Boudewijn M T Burgering
Journal:  Nat Rev Mol Cell Biol       Date:  2013-01-17       Impact factor: 94.444

6.  Dissecting allosteric effects of activator-coactivator complexes using a covalent small molecule ligand.

Authors:  Ningkun Wang; Jean M Lodge; Carol A Fierke; Anna K Mapp
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-21       Impact factor: 11.205

7.  Ordering a dynamic protein via a small-molecule stabilizer.

Authors:  Ningkun Wang; Chinmay Y Majmudar; William C Pomerantz; Jessica K Gagnon; Jack D Sadowsky; Jennifer L Meagher; Taylor K Johnson; Jeanne A Stuckey; Charles L Brooks; James A Wells; Anna K Mapp
Journal:  J Am Chem Soc       Date:  2013-02-22       Impact factor: 15.419

8.  Trithorax monomethylates histone H3K4 and interacts directly with CBP to promote H3K27 acetylation and antagonize Polycomb silencing.

Authors:  Feng Tie; Rakhee Banerjee; Alina R Saiakhova; Benny Howard; Kelsey E Monteith; Peter C Scacheri; Michael S Cosgrove; Peter J Harte
Journal:  Development       Date:  2014-03       Impact factor: 6.868

9.  Structural insights into TAZ2 domain-mediated CBP/p300 recruitment by transactivation domain 1 of the lymphopoietic transcription factor E2A.

Authors:  Marina R Lochhead; Alexandra D Brown; Alyssa C Kirlin; Seth Chitayat; Kim Munro; Jane E Findlay; George S Baillie; David P LeBrun; David N Langelaan; Steven P Smith
Journal:  J Biol Chem       Date:  2020-02-25       Impact factor: 5.157

10.  Recognition of the disordered p53 transactivation domain by the transcriptional adapter zinc finger domains of CREB-binding protein.

Authors:  Alexander S Krois; Josephine C Ferreon; Maria A Martinez-Yamout; H Jane Dyson; Peter E Wright
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-14       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.